• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYHB2100207 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100214 富马酸喹硫平缓释片 quetiapine fumarate Tablet, extended release Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100206 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100216 富马酸喹硫平缓释片 quetiapine fumarate Tablet, extended release Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100205 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100209 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100210 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100217 富马酸喹硫平缓释片 quetiapine fumarate Tablet, extended release Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100208 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JYHB2100215 富马酸喹硫平缓释片 quetiapine fumarate Tablet, extended release Chemical Drugs Supplementary Application 2021-03-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-19 view
JXHL2100085 阿地溴铵粉吸入剂 aclidinium bromide Inhalation Chemical Drugs(5.1) Import Drug Application 2021-03-12 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-12 view
JYHZ2100047 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JYHZ2100046 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JYHZ2100045 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JYHZ2100044 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JYHZ2100048 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JYHZ2100043 瑞舒伐他汀钙片 rosuvastatin calcium Tablet Chemical Drugs License Renew 2021-03-11 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-08 view
JXHL2100068 甲磺酸奥希替尼片 osimertinib mesylate Tablet Chemical Drugs(2.4) Import Drug Application 2021-03-03 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-02 view
JXHL2100067 甲磺酸奥希替尼片 osimertinib mesylate Tablet Chemical Drugs(2.4) Import Drug Application 2021-03-03 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd In Review 2021-03-02 view
JYHB2100141 甲磺酸奥希替尼片 osimertinib mesylate Tablet Chemical Drugs(5.1) Supplementary Application 2021-02-20 阿斯利康投资(中国)有限公司 Astrazeneca Investment (China) Co Ltd Certificate Issued 2021-09-23 view